8-KThe WireRoutine
Bylaw Amendment
Filed Feb 3, 2023 · 3y ago · Accession 0001193125-23-024123
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Stoke Therapeutics, Inc.
- Ticker
- STOK
- CIK
- 1623526
- Form type
- 8-K
- Filing date
- Feb 3, 2023
- Report date
- Feb 2, 2023
- Document
- d427161d8k.htm
- Size
- 364 KB